17.43 USD
↗ 4.13 (31.05%)AT CLOSE (11:59 AM EDT)
Eloxx Pharmaceuticals, Inc. Common Stock
ELOXNASDAQ • USD
17.03
↘ 0.40 (2.32%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
17.03
↘ 0.40 (2.32%)
Market: CLOSED
Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is currently trading at $17.43. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (62.7%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jul 31, 2026.
Open?$13.90
High?$18.42
Low?$13.79
Prev. Close?$13.30
Volume?53.4K
Avg. Volume?61.4K
VWAP?$16.03
Rel. Volume?0.87x
Bid / Ask
Bid?$16.45 × 100
Ask?$17.43 × 800
Spread?$0.98
Midpoint?$16.94
Valuation & Ratios
Market Cap?45.7M
Shares Out?3.9M
Float?3.1M
Float %?78.4%
P/E Ratio?N/A
P/B Ratio?-2.02
EPS?-$4.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Employees
7
Market Cap
45.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1998-12-11
Address
P.O. BOX 274
ARLINGTON, MA 02476
Phone: 781-577-5300
ARLINGTON, MA 02476
Phone: 781-577-5300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?60
Piotroski F-Score?0/9Weak
Altman Z-Score?-51.42Distress
Confidence?44%Low
Short InterestLow
Short % of Float?0.36%Low
Short Interest?11.0K
Days to Cover?1.0
Free Float3.1M
Avg Daily Volume58.1K
Settlement Date2026-07-15
Financial Health
Current Ratio?0.06Weak
Quick Ratio?0.06Weak
Cash Ratio?0.05Low
Debt/Equity?-0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-2.02CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?62.7%STRONG▾
Peers50
S&P93
ROA?-827.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$48.4M
Fundamentals ratios updated end of day